about
sameAs
Investigational drugs to treat methicillin-resistant Staphylococcus aureusCurrent updates on oxazolidinone and its significanceIn vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pyloriThe TB pandemic: an old problem seeking new solutions.Mechanisms for linezolid-induced anemia and thrombocytopenia.Linezolid-induced pure red cell aplasia in a patient with Staphylococcus epidermidis infection after allogeneic stem cell transplantation.In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceIntrapulmonary pharmacokinetics of linezolidIn vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens.In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedside.Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistanceAcquired antibiotic resistance genes: an overview.In vitro activities of new antimicrobials against Nocardia brasiliensisThe oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolates.Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.Linezolid: effectiveness and safety for approved and off-label indications.Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.Rivaroxaban in orthopedic surgery--a change of paradigm?Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Synthesis of oxazolidinones: rhodium-catalyzed C-H amination of N-mesyloxycarbamates.Predictive score of haematological toxicity in patients treated with linezolid.Linezolid Resistance in Staphylococci.In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia.In vitro activity of the new oxazolidinone AZD2563 against EnterococciIn vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound.Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells.Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.Molecular characterization of linezolid-resistant CoNS isolates in Japan.
P2860
Q26780246-8AB1657A-902D-465B-BDA6-C657AE724CC3Q26995628-D12023E0-8B66-49A6-AF62-E5B2A69C3945Q28534899-EB3E42FC-49BE-4118-A852-3E797743872EQ30360726-A761E24A-3660-4A14-9686-537F58F1E364Q33347167-B5C82EC5-845A-4460-9659-19C708D651F6Q33400641-1A2E49E2-3983-4D54-8803-AA0D7585C8BEQ33983749-F8C114C8-8F82-49AE-B4F6-AD735C496954Q34102811-CD66B0E8-D3BA-42B2-9EB9-371E1196868CQ34106719-2380D3E2-83AB-47F5-8570-7036BEFC1E52Q34110412-AEB9E733-53EB-4E3F-B7FD-D1D1543061F3Q34111344-2C2F6FAB-4FBD-4FC1-A5C6-2767B4EF939FQ34443415-3D27AAF8-8EA7-471D-958F-C8A63B86FCB4Q34871254-CE3DDDE2-0773-46E5-B8B8-C22234A4CC20Q35005203-E338010B-3C43-44B4-B222-7166ADA39AC0Q35451219-85933357-EDB7-46F4-8156-490AF466A44DQ35547190-55251F00-F6F9-4B0C-A797-29D7480434B6Q35666413-4D25C0C0-4305-448F-8501-F2A35335B2BBQ35848139-FF5E4EB2-102C-4046-B7AC-DCDC156A5416Q36240752-CB361183-C8BF-41DD-A814-F10D8872CA27Q36492132-6821F683-D7D9-4655-958A-C414635D0D4EQ36545088-8ED6AD5E-48F5-477C-8906-8D744F43E033Q36939685-9DE8318A-C5C5-4587-838A-F0D5A3FDB208Q36967288-5E916EBA-D911-43DF-BBBF-824D9BCE1AB1Q37568895-B6C7C98D-3717-4300-89BF-3842C04A959EQ37578092-F1A8A1C9-0A56-4B92-A86C-239A4F793409Q37785546-3536CFC4-8DF8-4F7E-8F72-7B7744B31160Q38830834-6F9DE84E-4E61-4B45-A7AC-4F6C5E951329Q38876028-10B7F6E4-7D06-4ACC-8A25-12163A1F1351Q38974364-EFCA902D-D980-4565-9478-C99140074E39Q39479010-FB0C5ECF-6CA1-4C7D-B13F-90A2428D0EF9Q39651829-65FB5FAD-2349-4B2B-AFCD-022948D3B424Q39658094-25FD3556-8E0C-4EFD-891C-206F8201FA22Q39658119-3A41B64F-D7C1-4D94-BEA1-C07795F0B5E7Q39671242-CD606A43-65D9-4FAC-956A-5DD84B257534Q39732000-4FAB3A8F-C0B0-4899-9EEA-B86C84A164B3Q39732005-F70C27FC-CCC9-4E86-A9EB-C60EB23BF276Q40165383-E1E8124C-D3F6-457B-A0DE-E3A9A19470DBQ40165422-8E9986AC-734F-4DCE-B38B-421D26C7A235Q41005410-1EBB7257-F69F-46CE-BD11-0763BED0F7F8Q41671056-93E04E03-A3E8-4044-B86D-ED7BBA264F41
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Oxazolidinones: a review
@ast
Oxazolidinones: a review
@en
Oxazolidinones: a review
@nl
type
label
Oxazolidinones: a review
@ast
Oxazolidinones: a review
@en
Oxazolidinones: a review
@nl
altLabel
Oxazolidinones
@en
Oxazolidinones
@nl
prefLabel
Oxazolidinones: a review
@ast
Oxazolidinones: a review
@en
Oxazolidinones: a review
@nl
P1433
P1476
Oxazolidinones: a review
@en
P2093
P2860
P356
10.2165/00003495-200059010-00002
P407
P577
2000-01-01T00:00:00Z
P6179
1050114081